sodium iodide i131 therapy capsule 2220 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 2220 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 2220 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 3330 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 3330 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 4070 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
sodium iodide i131 therapy capsule 814 mbq
biomedis m.b. d.o.o. - kapsula, trda - [131i]natrijev jodid
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - vsi drugi terapevtski izdelki - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.